Literature DB >> 22558471

Fallopian tube as main source for ovarian and pelvic (non-endometrial) serous carcinomas.

Wenxin Zheng, Oluwole Fadare.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22558471      PMCID： PMC3341675     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN： 1936-2625


× No keyword cloud information.
  44 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.

Authors:  C Bethan Powell; Lee-may Chen; Jane McLennan; Beth Crawford; Charles Zaloudek; Joseph T Rabban; Dan H Moore; John Ziegler
Journal:  Int J Gynecol Cancer       Date:  2011-07       Impact factor: 3.437

Review 3.  Precursor lesions of ovarian epithelial malignancy.

Authors:  K M Feeley; M Wells
Journal:  Histopathology       Date:  2001-02       Impact factor: 5.087

4.  Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

Authors:  Amy Finch; Mario Beiner; Jan Lubinski; Henry T Lynch; Pal Moller; Barry Rosen; Joan Murphy; Parviz Ghadirian; Eitan Friedman; William D Foulkes; Charmaine Kim-Sing; Teresa Wagner; Nadine Tung; Fergus Couch; Dominique Stoppa-Lyonnet; Peter Ainsworth; Mary Daly; Babara Pasini; Ruth Gershoni-Baruch; Charis Eng; Olufunmilayo I Olopade; Jane McLennan; Beth Karlan; Jeffrey Weitzel; Ping Sun; Steven A Narod
Journal:  JAMA       Date:  2006-07-12       Impact factor: 56.272

Review 5.  Pathology of epithelial ovarian tumors.

Authors:  H Krigman; R Bentley; S J Robboy
Journal:  Clin Obstet Gynecol       Date:  1994-06       Impact factor: 2.190

6.  Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.

Authors: 
Journal:  Oncologist       Date:  1996

7.  What is the true incidence of primary fallopian tube carcinoma?

Authors:  R. Woolas; I. Jacobs; A. Prys Davies; J. Leake; C. Brown; J.G. Grudzinskas; D. Oram
Journal:  Int J Gynecol Cancer       Date:  1994-11       Impact factor: 3.437

8.  Histological features of the contralateral ovary in patients with unilateral ovarian cancer: a case control study.

Authors:  F Tresserra; P J Grases; R Labastida; A Ubeda
Journal:  Gynecol Oncol       Date:  1998-12       Impact factor: 5.482

9.  Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by fellows and members of the Royal College of Obstetricians and Gynaecologists.

Authors:  I Jacobs; D Oram
Journal:  Br J Obstet Gynaecol       Date:  1989-05

Review 10.  The role of prophylactic oophorectomy in the avoidance of ovarian cancer.

Authors:  P E Schwartz
Journal:  Int J Gynaecol Obstet       Date:  1992-11       Impact factor: 3.561
View more
  10 in total

Review 1.  Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma.

Authors:  Yiying Wang; Maggie Mang; Yue Wang; Lijie Wang; Robert Klein; Beihua Kong; Wenxin Zheng
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.

Authors:  Christine Gruessner; Angelika Gruessner; Katherine Glaser; Nisreen AbuShahin; Yi Zhou; Cynthia Laughren; Heather Wright; Samantha Pinkerton; Xiaofang Yi; Jha'nae Stoffer; Masoud Azodi; Wenxin Zheng; Setsuko K Chambers
Journal:  Cancer Prev Res (Phila)       Date:  2014-06-20

3.  Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.

Authors:  Lin Jia; Zeng Yuan; Yiying Wang; Janiel M Cragun; Beihua Kong; Wenxin Zheng
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

4.  Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.

Authors:  Christine Gruessner; Angelika Gruessner; Katherine Glaser; Nisreen Abushahin; Cynthia Laughren; Wenxin Zheng; Setsuko K Chambers
Journal:  Am J Cancer Res       Date:  2014-01-15       Impact factor: 6.166

5.  Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection.

Authors:  Hao Chen; Robert Klein; Stacy Arnold; Yiying Wang; Setsuko Chambers; Wenxin Zheng
Journal:  J Vis Exp       Date:  2017-07-25       Impact factor: 1.355

6.  Inhibitory role of prohibitin in human ovarian epithelial cancer.

Authors:  Lin Jia; Jian-Min Ren; Yi-Ying Wang; Yu Zheng; Hui Zhang; Qing Zhang; Bei-Hua Kong; Wen-Xin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

7.  Incessant ovulation and ovarian cancer - a hypothesis re-visited.

Authors:  M F Fathalla
Journal:  Facts Views Vis Obgyn       Date:  2013

8.  Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy.

Authors:  Hao Chen; Robert Klein; Stacy Arnold; Setsuko Chambers; Wenxin Zheng
Journal:  Cancer Cell Int       Date:  2016-10-01       Impact factor: 5.722

9.  Primary fallopian tube carcinoma: review of MR imaging findings.

Authors:  Filipe Veloso Gomes; João Lopes Dias; Rita Lucas; Teresa Margarida Cunha
Journal:  Insights Imaging       Date:  2015-07-07

Review 10.  Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention.

Authors:  Brendan Ffrench; Claudia Gasch; John J O'Leary; Michael F Gallagher
Journal:  Mol Cancer       Date:  2014-12-11       Impact factor: 27.401
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.